How could new attorney general impact cannabis rescheduling? (Newsletter: April 3, 2026)
FDA CBD memo; MA anti-marijuana initiative faces lawsuit; DC mayor’s cannabis drinks plan; TX medical marijuana licenses; VA prepares for legal sales Subscribe to receive Marijuana Moment’s newsletter …
Meriden may add zoning amendments for new cannabis and THC businesses
The company is proposing an amendment for cannabis transporters to include the warehousing of finished cannabis goods for distribution, …
Recreational cannabis sales in Minnesota top $50 million in last six months since legal market took off
Eric Taubel, executive director of the Office of Cannabis Management, said he expects monthly sales to double in the coming months and years.
Why Tilray and other cannabis stocks just had their best week of 2026
Tilray Brands, Canopy Growth, and Curaleaf Holdings stocks are surging after the FDA says it won’t enforce some regulations for CBD products.
Fight over mandatory cannabis testing picks up steam as bill heads to floor
Maine remains the only state in the country where medical marijuana is not required to be tested for purity or contaminants. Efforts to remedy that have tried and failed in past years.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Marijuana Companies Eye Investment Boom After Trump Admin Reschedules Drug
Following the recent drug rescheduling from the Trump Administration, medicinal marijuana companies are preparing to raise nearly $20 million in private funding.
Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
By Puyaan Singh and Christy Santhosh April 30 (Reuters) – Companies developing cannabis-based medicines say U.S. moves to loosen restrictions on the drug could unlock private funding and the public …
It Ain’t Just Bud: Black-Owned Brands That Contribute To The Cannabis Industry
How big is the Black-owned cannabis market? The legal cannabis industry generates billions of dollars annually—reaching an estimated $40 billion in 2024—but suffers from a significant imbalance in …
How MSO TerrAscend is leading the cannabis industry forward
TerrAscend will leverage federal rescheduling of medical cannabis to drive growth, shape policy with a focus on compliance and expansion.
Mayor Bowser introduces bill that allows medical cannabis shops to partner with local breweries
The bill would allow cannabis shops and breweries to partner up and create cannabis-infused, alcohol-free beverages.
Why Ethos Cannabis Is Closing Dispensaries On 4/20
Instead of chasing 4/20 crowds and deep discounts, Ethos Cannabis is closing its stores—signaling a rethink of the industry’s biggest sales day.
Texas Officials Approve New Medical Marijuana Business Licenses Under Plan To Expand Patient Access
Texas officials have conditionally approved more new medical marijuana business licenses as part of a law that’s being implemented to significantly expand the state’s cannabis program. The Department …
Cannabis rescheduling: potential distant impacts on healthcare providers
Kiliaen Strong of Dilworth Paxson LLP discusses the likely limited practical impact of potential rescheduling of cannabis without further developments by federal agencies, states or Congress.
Smaller Denver Cannabis Growers Closing, Freeing Up Warehouses
In March, Vireo closed a north Denver grow owned by PharmaCann Inc., which it acquired last year, according to the Denver Business Journal. The closure of the facility at 5131 Franklin St. will cut …
Recent Comments